Stacy Price
Directeur Technique/Scientifique/R&D chez INVIVYD, INC.
Fortune : - $ au 30/04/2024
Postes actifs de Stacy Price
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INVIVYD, INC. | Directeur Technique/Scientifique/R&D | 01/03/2023 | - |
Historique de carrière de Stacy Price
Anciens postes connus de Stacy Price
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AKOUOS | Directeur Technique/Scientifique/R&D | 01/11/2021 | - |
| ALAUNOS THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - | - |
Formation de Stacy Price
| Tufts University | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 3 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| INVIVYD, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Akouos, Inc.
 Akouos, Inc. BiotechnologyHealth Technology Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA. | Health Technology |
- Bourse
- Insiders
- Stacy Price
- Expérience
